NCT01002755 Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE2
NCT00990587 Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy Status COMPLETED Phase PHASE1
NCT00975975 Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer Status COMPLETED Phase PHASE2
NCT00974233 Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL Status COMPLETED Phase PHASE2
NCT00963495 Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy Status TERMINATED Phase PHASE1
NCT00962715 Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia Status WITHDRAWN Phase PHASE1/PHASE2
NCT00949988 A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia Status TERMINATED Phase PHASE1/PHASE2
NCT00946023 Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab Status TERMINATED Phase PHASE2
NCT00934986 Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia Status COMPLETED Phase NA
NCT00931645 Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE3
NCT00918723 Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00899431 Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) Status TERMINATED Phase PHASE2
NCT00899353 Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) Status TERMINATED Phase PHASE2
NCT00898079 Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Status COMPLETED Phase N/A
NCT00880815 Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant Status COMPLETED Phase PHASE1
NCT00873457 Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE2
NCT00872976 Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia Status WITHDRAWN Phase PHASE1